GO:0005767 secondary lysosome: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005767 secondary lysosome is a cellular component defined as a vacuole formed by fusion of a lysosome with an autosome or a primary phagosome.
• Secondary lysosomes are the degradative endpoint of autophagy and phagocytosis, where cargo is broken down by acid hydrolases such as cathepsins.
• Fusion of autophagosomes with lysosomes requires SNARE proteins including VAMP8, and its stabilization by DRAM1 enables this step.
• Lysosomal dysfunction in secondary lysosomes contributes to cancer metastasis, chemoresistance, and neuroinflammation [5,8].
• Progranulin (GRN) loss impairs lysosomal function and causes a lysosomal storage disorder that can be rescued by progranulin biologics.
• CRISPR knockout, knock-in, and overexpression models are essential to dissect the molecular machinery of secondary lysosome formation and function [1,4].
Description
The secondary lysosome (GO:0005767) is a cellular component that represents the active degradative compartment formed when a lysosome fuses with an autosome (autophagosome) or a primary phagosome. This fusion event is the terminal step of autophagy and phagocytosis, allowing the delivery of cytoplasmic cargo or engulfed material into the acidic lysosomal lumen for breakdown by hydrolases. Secondary lysosomes are therefore central to cellular quality control, nutrient recycling, and host defense. In cancer, secondary lysosome function supports tumor cell survival under metabolic stress and promotes metastatic extravasation by enabling autophagosome-lysosome fusion. In pancreatic cancer, lysosomal cathepsin B activity in tumor-associated macrophages is fueled by increased glucose metabolism and O-GlcNAcylation, linking secondary lysosome biology to metastasis and chemoresistance. In the brain, microglial lysosomal dysfunction disrupts autophagic flux and exacerbates post-stroke neuroinflammation. Consequently, researchers studying secondary lysosomes need robust genetic models to interrogate the genes controlling their formation, cargo degradation, and downstream signaling.
secondary lysosome At A Glance
| GO ID | GO:0005767 |
|---|---|
| GO term | secondary lysosome |
| Ontology | cellular_component |
| Synonym | none |
| Major function | Degradation of autophagic and phagocytic cargo after fusion of lysosome with autosome or primary phagosome |
| Related processes | Autophagy, phagocytosis, endolysosomal degradation |
| Key molecular players | VAMP8, DRAM1, cathepsins, progranulin (GRN) |
| Disease relevance | Cancer metastasis, chemoresistance, lysosomal storage disorders, neuroinflammation |
What Is GO:0005767?
According to the Gene Ontology, GO:0005767 secondary lysosome is a vacuole formed by the fusion of a lysosome with an organelle (autosome) or with a primary phagosome. In other words, it is the hybrid organelle that results when a primary lysosome merges with an autophagosome or a phagosome, creating an acidic, hydrolase-rich compartment where the delivered cargo is degraded.
Why Is secondary lysosome Important in Cell Biology?
Secondary lysosomes are essential for cellular homeostasis because they execute the final degradation steps of autophagy and phagocytosis. Defects in their formation or function lead to accumulation of undegraded cargo, altered signaling, and disease. In cancer, secondary lysosome activity supports metastasis and chemoresistance, and in the brain, lysosomal dysfunction in microglia drives neuroinflammation after stroke. Understanding the molecular control of secondary lysosome biogenesis is therefore critical for developing therapies targeting lysosomal pathways.
• Secondary lysosomes are the degradative endpoint of autophagy and phagocytosis.
• They are required for recycling nutrients and clearing damaged organelles.
• Lysosomal cathepsin B in tumor-associated macrophages promotes cancer metastasis and chemoresistance.
• Impaired secondary lysosome function contributes to neuroinflammation after stroke.
• Progranulin (GRN) deficiency causes a lysosomal storage disorder that can be rescued by progranulin biologics.
• Secondary lysosome components are potential therapeutic targets in cancer and neurodegeneration [3,5,8].
• CRISPR screens can identify genes required for autophagosome-lysosome fusion.
• Secondary lysosome markers are used to monitor autophagic flux in research and diagnostics.
What Happens During secondary lysosome?
Fusion of lysosome with autophagosome
In simple terms: A lysosome merges with an autophagosome to form a secondary lysosome.
The formation of a secondary lysosome begins when a lysosome fuses with an autophagosome. This fusion is mediated by SNARE proteins, including VAMP8, which is stabilized by DRAM1 to enable autophagosome-lysosome fusion. This step is essential for delivering autophagic cargo into the acidic lysosomal lumen for degradation.
Fusion of lysosome with phagosome
In simple terms: A lysosome merges with a phagosome to digest engulfed material.
When a cell engulfs extracellular particles, a primary phagosome forms and subsequently fuses with a lysosome to create a secondary lysosome. This process is critical for efferocytosis and clearance of apoptotic cells, and it reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis.
Cargo degradation by acid hydrolases
In simple terms: Enzymes inside the secondary lysosome break down the delivered cargo.
Once fusion is complete, acid hydrolases such as cathepsins degrade the cargo. Cathepsin B activity in tumor-associated macrophages is enhanced by O-GlcNAcylation driven by increased glucose metabolism, which promotes cancer metastasis and chemoresistance.
Regulation by chaperone-mediated autophagy
In simple terms: Chaperone-mediated autophagy can influence secondary lysosome activity and downstream signaling.
Chaperone-mediated autophagy modulates the stability of Snail protein, impacting breast cancer metastasis. This indicates that secondary lysosome function is integrated with broader lysosomal degradation pathways that control key oncogenic proteins.
Lysosomal dysfunction and neuroinflammation
In simple terms: When secondary lysosomes fail, toxic materials build up and cause inflammation.
Microglial NLRC5 drives lysosomal dysfunction, disrupting autophagic flux and promoting post-stroke neuroinflammation. This highlights the importance of secondary lysosome function in maintaining brain homeostasis.
Key Genes Involved in GO:0005767 secondary lysosome
The following genes and proteins are experimentally implicated in secondary lysosome biology, including fusion, degradation, and disease-associated dysfunction.
| Gene | Major Role | Research Relevance |
|---|---|---|
| VAMP8 | SNARE protein mediating autophagosome-lysosome fusion | Required for secondary lysosome formation; target for autophagy studies |
| DRAM1 | Stabilizes VAMP8 to enable fusion | Promotes metastatic extravasation; potential therapeutic target |
| CTSB | Lysosomal cathepsin B; degrades cargo | O-GlcNAcylation enhances activity; linked to metastasis and chemoresistance |
| GRN | Progranulin; lysosomal function and survival | Loss causes lysosomal storage disorder; rescue by progranulin biologic |
| NLRC5 | Microglial lysosomal dysfunction | Drives autophagic flux disruption and neuroinflammation |
| SNAI1 | Snail; regulated by chaperone-mediated autophagy | Modulates breast cancer metastasis |
| PCSK9 | Sterol-dependent metastatic organ choice | Influences pancreatic cancer metastasis |
| FSP1 | Lymph node environment targetability | Melanoma metastasis |
| LAMP1 | Lysosomal membrane protein | Marker for secondary lysosomes (generic) |
| LAMP2 | Lysosomal membrane protein | Marker for secondary lysosomes (generic) |
| CTSD | Lysosomal cathepsin D | Cargo degradation (generic) |
| CTSL | Lysosomal cathepsin L | Cargo degradation (generic) |
| RAB7 | Late endosome/lysosome trafficking | Fusion regulation (generic) |
| STX17 | Autophagosomal SNARE | Fusion with lysosome (generic) |
| SNAP29 | SNARE complex component | Fusion regulation (generic) |
| EPG5 | Autophagy receptor for lysosome fusion | Fusion specificity (generic) |
| TFEB | Transcription factor for lysosomal biogenesis | Regulates lysosomal gene expression (generic) |
| mTORC1 | Nutrient sensor inhibiting autophagy | Regulates secondary lysosome formation (generic) |
How Is secondary lysosome Regulated?
Secondary lysosome formation is regulated by nutrient-sensing pathways such as mTORC1, which inhibits autophagy under nutrient-rich conditions. Chaperone-mediated autophagy modulates Snail protein stability, linking lysosomal degradation to epithelial-mesenchymal transition. Additionally, O-GlcNAcylation of cathepsin B in tumor-associated macrophages enhances lysosomal activity and promotes metastasis. Microglial NLRC5 drives lysosomal dysfunction and disrupts autophagic flux, indicating that inflammatory signaling can impair secondary lysosome function.
secondary lysosome and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GRN | Lysosomal storage disorder | GRN knockout cells; rescue with progranulin biologic |
| CTSB | Cancer metastasis and chemoresistance | CTSB knockout or overexpression in macrophages |
| VAMP8 | Metastatic extravasation | VAMP8 knockout or DRAM1-stabilized knock-in |
| NLRC5 | Post-stroke neuroinflammation | NLRC5 knockout microglia |
| SNAI1 | Breast cancer metastasis | SNAI1 knockout or point mutation |
Cancer metastasis and chemoresistance
Secondary lysosome activity supports cancer progression. In pancreatic cancer, efferocytosis reprograms the tumor microenvironment to promote liver metastasis. Increased glucose metabolism in tumor-associated macrophages fuels O-GlcNAcylation of lysosomal cathepsin B, enhancing metastasis and chemoresistance. VAMP8 stabilization by DRAM1 enables autophagosome-lysosome fusion and promotes metastatic extravasation. PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer, and the lymph node environment drives FSP1 targetability in metastasizing melanoma.
Lysosomal storage disorders
Loss of progranulin (GRN) function causes a lysosomal storage disorder that can be rescued with a brain-penetrant progranulin biologic. This demonstrates that secondary lysosome dysfunction underlies neurodegenerative disease pathology.
Neuroinflammation and stroke
Microglial NLRC5 drives lysosomal dysfunction, disrupting autophagic flux and promoting post-stroke neuroinflammation. This links secondary lysosome impairment to inflammatory brain injury.
Breast cancer metastasis
Chaperone-mediated autophagy modulates Snail protein stability, impacting breast cancer metastasis. This suggests that lysosomal degradation pathways influence metastatic potential.
From secondary lysosome-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does VAMP8 mediate autophagosome-lysosome fusion? | VAMP8 knockout cells |
| Does DRAM1 stabilization of VAMP8 promote metastasis? | DRAM1 overexpression or knockout |
| Does O-GlcNAcylation of cathepsin B enhance metastasis? | CTSB point mutation at O-GlcNAc sites |
| Can progranulin rescue GRN loss? | GRN knockout cells treated with progranulin biologic |
| Does NLRC5 drive lysosomal dysfunction? | NLRC5 knockout microglia |
| Does Snail stability depend on chaperone-mediated autophagy? | SNAI1 knock-in with degradation-resistant mutation |
How to Study the secondary lysosome Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Colocalization of lysosome and autophagosome markers | Assess secondary lysosome formation |
| Proteomics | Protein composition and modifications | Identify cathepsin modifications |
| CRISPR screen | Genes required for fusion | Discover novel regulators |
| RNA-seq | Transcriptional changes | Evaluate lysosomal gene expression |
| Western blot | Protein levels and cleavage | Monitor cathepsin processing |
| Live-cell imaging | Dynamics of fusion events | Track secondary lysosome formation |
| LysoTracker staining | Acidic organelle content | Measure lysosomal mass |
Fluorescence microscopy
Colocalization of lysosomal markers (LAMP1) with autophagosomal markers (LC3) visualizes secondary lysosome formation. This method is used to assess autophagic flux and fusion efficiency.
Proteomics
Mass spectrometry can identify proteins enriched in secondary lysosomes and detect post-translational modifications such as O-GlcNAcylation of cathepsin B.
CRISPR screens
Genome-wide CRISPR knockout screens can identify genes required for autophagosome-lysosome fusion and secondary lysosome function.
RNA-seq
Transcriptomic profiling reveals changes in lysosomal gene expression upon secondary lysosome dysfunction or therapeutic intervention [3,8].
How CRISPR Can Be Used to Study GO:0005767 secondary lysosome
Knockout
CRISPR knockout of genes such as VAMP8 or DRAM1 can abolish secondary lysosome formation, allowing researchers to test their requirement for autophagosome-lysosome fusion.
Point Mutation
Introducing point mutations in cathepsin B at O-GlcNAcylation sites can determine whether this modification is required for its enhanced activity and metastasis promotion.
Knock-in
Knock-in of tagged LAMP1 or LC3 enables live-cell imaging of secondary lysosomes and autophagosomes.
Overexpression
Overexpression of DRAM1 or VAMP8 can enhance autophagosome-lysosome fusion and promote metastatic extravasation, providing gain-of-function models.
How EDITGENE Supports secondary lysosome Research
Researchers studying secondary lysosome-related genes often need to determine whether a candidate gene is causally involved in fusion, degradation, or disease progression. EDITGENE provides custom CRISPR cell models to interrogate these questions with precision.
Contact EDITGENE today to design your custom CRISPR model for secondary lysosome research.
Frequently Asked Questions About secondary lysosome
What is a secondary lysosome?
A secondary lysosome (GO:0005767) is a vacuole formed by the fusion of a lysosome with an autosome or a primary phagosome, where cargo is degraded.
What genes are involved in secondary lysosome formation?
Key genes include VAMP8, DRAM1, CTSB, GRN, and NLRC5, which regulate fusion, degradation, and dysfunction [3,4,5,8].
How is a secondary lysosome formed?
It forms when a lysosome fuses with an autophagosome or phagosome, a process mediated by SNARE proteins such as VAMP8.
What is the function of a secondary lysosome?
It degrades autophagic and phagocytic cargo using acid hydrolases like cathepsins.
How does secondary lysosome dysfunction cause disease?
Dysfunction leads to cargo accumulation, neuroinflammation, and cancer progression [5,8].
What is the difference between primary and secondary lysosome?
A primary lysosome is a newly formed hydrolase-rich vesicle; a secondary lysosome is formed after fusion with an autosome or phagosome.
Can CRISPR be used to study secondary lysosomes?
Yes, CRISPR knockout, knock-in, and overexpression models are used to dissect gene function in secondary lysosome biology [4,5].
What diseases are linked to secondary lysosomes?
Cancer metastasis, chemoresistance, lysosomal storage disorders, and neuroinflammation [3,5,8].
How to measure secondary lysosome formation?
Fluorescence microscopy of LAMP1 and LC3 colocalization is a common method.
What is the GO ID for secondary lysosome?
The GO ID is GO:0005767.
Conclusion
The secondary lysosome (GO:0005767) is a critical cellular component formed by the fusion of lysosomes with autosomes or phagosomes. It serves as the degradative hub for autophagy and phagocytosis, with profound implications for cancer, neurodegeneration, and inflammation [3,4,5,8]. Understanding its molecular regulation through genes such as VAMP8, DRAM1, and CTSB offers opportunities for therapeutic intervention. EDITGENE provides comprehensive CRISPR solutions to accelerate research on secondary lysosome biology.
References
- 1. Rademaker G et al.. 2025. PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer.. Nature 643(8074):1381-1390 PMID: 40399683
- 2. Astuti Y et al.. 2024. Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis.. Nat Cancer 5(5):774-790 PMID: 38355776
- 3. Logan T et al.. 2021. Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic.. Cell 184(18):4651-4668.e25 PMID: 34450028
- 4. Zhang R et al.. 2025. VAMP8 stabilization by DRAM1 enables autophagosome-lysosome fusion and promotes metastatic extravasation.. Autophagy 21(11):2531-2533 PMID: 40884094
- 5. Shi Q et al.. 2022. Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance.. Cancer Cell 40(10):1207-1222.e10 PMID: 36084651
- 6. Palma M et al.. 2026. Lymph node environment drives FSP1 targetability in metastasizing melanoma.. Nature 649(8096):477-486 PMID: 41193799
- 7. Ryu KJ et al.. 2024. Chaperone-mediated autophagy modulates Snail protein stability: implications for breast cancer metastasis.. Mol Cancer 23(1):227 PMID: 39390584
- 8. Xu S et al.. 2025. Microglial NLRC5 drives lysosomal dysfunction to disrupt autophagic flux and promote post-stroke neuroinflammation.. J Neuroinflammation 22(1):253 PMID: 41174779
